The 3q-AML are very sensitive to the inhibition of Poly [ADP-ribose] polymerase 1 (PARP1) that decreases MECOM(EVI1) expression, providing an interesting strategy for these AMLs [9]. Here, RUNX1 is linked to acute myeloid leukemia.